Bacterial ammeline metabolism via guanine deaminase.
Melamine toxicity in mammals has been attributed to the blockage of kidney tubules by insoluble complexes of melamine with cyanuric acid or uric acid. Bacteria metabolize melamine via three consecutive deamination reactions to generate cyanuric acid. The second deamination reaction, in which ammeline is the substrate, is common to many bacteria, but the genes and enzymes responsible have not been previously identified. Here, we combined bioinformatics and experimental data to identify guanine deaminase as the enzyme responsible for this biotransformation. The ammeline degradation phenotype was demonstrated in wild-type Escherichia coli and Pseudomonas strains, including E. coli K12 and Pseudomonas putida KT2440. Bioinformatics analysis of these and other genomes led to the hypothesis that the ammeline deaminating enzyme was guanine deaminase. An E. coli guanine deaminase deletion mutant was deficient in ammeline deaminase activity, supporting the role of guanine deaminase in this reaction. Two guanine deaminases from disparate sources (Bradyrhizobium japonicum USDA 110 and Homo sapiens) that had available X-ray structures were purified to homogeneity and shown to catalyze ammeline deamination at rates sufficient to support bacterial growth on ammeline as a sole nitrogen source. In silico models of guanine deaminase active sites showed that ammeline could bind to guanine deaminase in a similar orientation to guanine, with a favorable docking score. Other members of the amidohydrolase superfamily that are not guanine deaminases were assayed in vitro, and none had substantial ammeline deaminase activity. The present study indicated that widespread guanine deaminases have a promiscuous activity allowing them to catalyze a key reaction in the bacterial transformation of melamine to cyanuric acid and potentially contribute to the toxicity of melamine.
Seffernick
Jennifer L
JL
Department of Biochemistry, Molecular Biology & Biophysics, University of Minnesota, St. Paul, MN 55108, USA.
Dodge
Anthony G
AG
Sadowsky
Michael J
MJ
Bumpus
John A
JA
Wackett
Lawrence P
LP
D001426:Bacterial Proteins / Q000378:metabolism*; D020369:Bradyrhizobium / Q000201:enzymology* / Q000235:genetics / Q000378:metabolism; D020134:Catalytic Domain; D016000:Cluster Analysis; D019295:Computational Biology; D048168:Escherichia coli K12 / Q000201:enzymology* / Q000235:genetics / Q000378:metabolism; D017353:Gene Deletion; D023061:Gene Order; D005798:Genes, Bacterial; D006148:Guanine Deaminase / Q000302:isolation & purification / Q000378:metabolism*; D006801:Humans; D007700:Kinetics; D053858:Metabolic Networks and Pathways; D008958:Models, Molecular; D015394:Molecular Structure; D010802:Phylogeny; D017434:Protein Structure, Tertiary; D016958:Pseudomonas putida / Q000201:enzymology* / Q000235:genetics / Q000378:metabolism; D017386:Sequence Homology, Amino Acid; D013379:Substrate Specificity; D014227:Triazines / Q000378:metabolism*
D001426:Bacterial Proteins; C402297:GDA protein, human; D014227:Triazines; D006148:Guanine Deaminase; C000089:ammeline